Walleye Trading LLC Bluebird Bio, Inc. Call Options Transaction History

Walleye Trading LLC

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $1,884 - $4,932	600 New	600 $1,000
Q2 2022 Aug 08, 2022	SELL	$2.94 - $5.23 $2,940 - $5,230	-1,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $2,849 - $7,420	700 Added 233.33%	1,000 $5,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $74,368 - $135,373	-8,300 Reduced 96.51%	300 $3,000
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $8,992 - $16,800	800 Added 10.26%	8,600 $164,000
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $140,712 - $172,302	7,800 New	7,800 $249,000
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $99,000 - $136,512	-3,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $48,216 - $61,250	1,400 Added 63.64%	3,600 $194,000
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $371,544 - $629,789	-13,700 Reduced 86.16%	2,200 $134,000
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $219,744 - $533,400	8,400 Added 112.0%	15,900 $731,000
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $23,480 - $30,835	500 Added 7.14%	7,500 $658,000
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $11,894 - $18,620	200 Added 2.94%	7,000 $643,000
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $235,104 - $326,151	-3,100 Reduced 31.31%	6,800 $865,000
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $605,736 - $978,634	9,400 Added 1880.0%	9,900 $1.56 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $29,550 - $46,630	500 New	500 $50,000
Q3 2017 Nov 14, 2017	SELL	$57.74 - $91.42 $5,774 - $9,142	-100 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	100	100 $11,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.